Dataset Information

DEEPScreen: high performance drug-target interaction prediction with convolutional neural networks using 2-D structural compound representations.

ABSTRACT: The identification of physical interactions between drug candidate compounds and target biomolecules is an important process in drug discovery. Since conventional screening procedures are expensive and time consuming, computational approaches are employed to provide aid by automatically predicting novel drug-target interactions (DTIs). In this study, we propose a large-scale DTI prediction system, DEEPScreen, for early stage drug discovery, using deep convolutional neural networks. One of the main advantages of DEEPScreen is employing readily available 2-D structural representations of compounds at the input level instead of conventional descriptors that display limited performance. DEEPScreen learns complex features inherently from the 2-D representations, thus producing highly accurate predictions. The DEEPScreen system was trained for 704 target proteins (using curated bioactivity data) and finalized with rigorous hyper-parameter optimization tests. We compared the performance of DEEPScreen against the state-of-the-art on multiple benchmark datasets to indicate the effectiveness of the proposed approach and verified selected novel predictions through molecular docking analysis and literature-based validation. Finally, JAK proteins that were predicted by DEEPScreen as new targets of a well-known drug cladribine were experimentally demonstrated in vitro on cancer cells through STAT3 phosphorylation, which is the downstream effector protein. The DEEPScreen system can be exploited in the fields of drug discovery and repurposing for in silico screening of the chemogenomic space, to provide novel DTIs which can be experimentally pursued. The source code, trained "ready-to-use" prediction models, all datasets and the results of this study are available at ; https://github.com/cansyl/DEEPscreen.

SUBMITTER: Rifaioglu AS

PROVIDER: S-EPMC7643205 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

DEEPScreen: high performance drug-target interaction prediction with convolutional neural networks using 2-D structural compound representations.

Rifaioglu Ahmet Sureyya AS Nalbat Esra E Atalay Volkan V Martin Maria Jesus MJ Cetin-Atalay Rengul R Doğan Tunca T

Chemical science 20200108 9

The identification of physical interactions between drug candidate compounds and target biomolecules is an important process in drug discovery. Since conventional screening procedures are expensive and time consuming, computational approaches are employed to provide aid by automatically predicting novel drug-target interactions (DTIs). In this study, we propose a large-scale DTI prediction system, DEEPScreen, for early stage drug discovery, using deep convolutional neural networks. One of the ma ...[more]

PMID: 33209251

Similar Datasets

Project description:The application of convolutional neural networks (ConvNets) to harness high-content screening images or 2D compound representations is gaining increasing attention in drug discovery. However, existing applications often require large data sets for training, or sophisticated pretraining schemes. Here, we show using 33 IC50 data sets from ChEMBL 23 that the in vitro activity of compounds on cancer cell lines and protein targets can be accurately predicted on a continuous scale from their Kekulé structure representations alone by extending existing architectures (AlexNet, DenseNet-201, ResNet152 and VGG-19), which were pretrained on unrelated image data sets. We show that the predictive power of the generated models, which just require standard 2D compound representations as input, is comparable to that of Random Forest (RF) models and fully-connected Deep Neural Networks trained on circular (Morgan) fingerprints. Notably, including additional fully-connected layers further increases the predictive power of the ConvNets by up to 10%. Analysis of the predictions generated by RF models and ConvNets shows that by simply averaging the output of the RF models and ConvNets we obtain significantly lower errors in prediction for multiple data sets, although the effect size is small, than those obtained with either model alone, indicating that the features extracted by the convolutional layers of the ConvNets provide complementary predictive signal to Morgan fingerprints. Lastly, we show that multi-task ConvNets trained on compound images permit to model COX isoform selectivity on a continuous scale with errors in prediction comparable to the uncertainty of the data. Overall, in this work we present a set of ConvNet architectures for the prediction of compound activity from their Kekulé structure representations with state-of-the-art performance, that require no generation of compound descriptors or use of sophisticated image processing techniques. The code needed to reproduce the results presented in this study and all the data sets are provided at https://github.com/isidroc/kekulescope .

Project description:The prediction of breeding values and phenotypes is of central importance for both livestock and crop breeding. In this study, we analyze the use of artificial neural networks (ANN) and, in particular, local convolutional neural networks (LCNN) for genomic prediction, as a region-specific filter corresponds much better with our prior genetic knowledge on the genetic architecture of traits than traditional convolutional neural networks. Model performances are evaluated on a simulated maize data panel (n = 10,000; p = 34,595) and real Arabidopsis data (n = 2,039; p = 180,000) for a variety of traits based on their predictive ability. The baseline LCNN, containing one local convolutional layer (kernel size: 10) and two fully connected layers with 64 nodes each, is outperforming commonly proposed ANNs (multi layer perceptrons and convolutional neural networks) for basically all considered traits. For traits with high heritability and large training population as present in the simulated data, LCNN are even outperforming state-of-the-art methods like genomic best linear unbiased prediction (GBLUP), Bayesian models and extended GBLUP, indicated by an increase in predictive ability of up to 24%. However, for small training populations, these state-of-the-art methods outperform all considered ANNs. Nevertheless, the LCNN still outperforms all other considered ANNs by around 10%. Minor improvements to the tested baseline network architecture of the LCNN were obtained by increasing the kernel size and of reducing the stride, whereas the number of subsequent fully connected layers and their node sizes had neglectable impact. Although gains in predictive ability were obtained for large scale data sets by using LCNNs, the practical use of ANNs comes with additional problems, such as the need of genotyping all considered individuals, the lack of estimation of heritability and reliability. Furthermore, breeding values are additive by design, whereas ANN-based estimates are not. However, ANNs also comes with new opportunities, as networks can easily be extended to account for additional inputs (omics, weather etc.) and outputs (multi-trait models), and computing time increases linearly with the number of individuals. With advances in high-throughput phenotyping and cheaper genotyping, ANNs can become a valid alternative for genomic prediction.

Dataset Information

DEEPScreen: high performance drug-target interaction prediction with convolutional neural networks using 2-D structural compound representations.

Publications

DEEPScreen: high performance drug-target interaction prediction with convolutional neural networks using 2-D structural compound representations.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets